Online Intervention for Reduction of Ultra-processed Products and Increase of Physical Activity in University Students (UNISALUD)

March 22, 2024 updated by: University of Guadalajara

An Internet-based Self-help Intervention for the Reduction of Consumption of Ultra-processed Products and Increase of Physical Activity in Mexican University Population: Study Protocol for a Randomized Controlled Trial

This study evaluates the effectiveness of an online Multi-component psychological intervention, that is focused on reducing the consumption of ultra processed foods and increase the frequency of performing Physical Activity. At the same time to observe the effect on symptoms of anxiety, depression and stress.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Ultra Processed Products are edible products made primarily or entirely from substances derived from food. Its manufacture is based on industrial processes such as hydrogenation, extrusion and molding, pre-processed for frying, and that cannot be done at home. A sedentary lifestyle or physical inactivity is associated with loss of muscle mass and weight gain. In contrast, physical activity acts as a protector against non-communicable diseases such as type 2 diabetes, cardiovascular diseases and some types of cancer. AF levels are determined through Units of Measurement of the Metabolic Rate. Also the consumption of Ultra Processed Products and sedentary behaviors have been associated with affectations on people's health; An example of this is the association that exists between them and has been associated with an increased risk of suffering from depression, anxiety, and stress.

Internet-based interventions had a large effect on cognitive dietary outcomes, a moderate effect on dietary intake and weight, and a small effect on physical activity outcomes. In concrete, self-applied interventions can be an option to arrive at a great number of participants. In such intervention the user receives the treatment solely through a web platform or an App. Such interventions are usually composed of videos, text and audios. Different reviews regarding self-administered treatments via the internet and computer-based treatments have been found them to be effective to achieve their goals.

The intervention will follow the principles of User Experience, with this ensuring that the design characteristics of the tool will meet the desired requirements to be perceived as easy to use, attractive and useful.

This study will be conducted through a randomized controlled clinical superiority trial with two independent groups. It will include intra subjects at five evaluation moments: 1) pretest, 2) middle of the intervention, 3) post-test, 4) follow up at three months and 5) follow up at 6 months.

Participants will be randomly assigned to one of two groups: experimental group, "UNISALUD", composed of 9 sessions and interactive elements such as videos, audios and infographics; control group, will be the waiting list group, the participants in this group will not receive the treatment immediately, it will be measured one time and then a second time 27 days later than the experimental group when it is calculated that the first group has carried out the 9 sessions.

The measures will be the following:

  1. Frequency of Consumption of ultra-processed foods
  2. International Physical Activity Questionnaire
  3. Health Action Process Approach
  4. Self-Efficacy Eating Consumption Scale
  5. Self-Efficacy Exercise Questionnaire
  6. Stress Perception
  7. Generalized Anxiety Disorder Scale
  8. The Center for Epidemiological Studies Depression Scale
  9. System Usability Scale

Study Type

Interventional

Enrollment (Estimated)

176

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Have a device (cell phone, computer or tablet) with internet access.
  • Have agreed to participate by giving tacit consent.
  • Be enrolled in any degree from a university in Mexico

Exclusion Criteria:

  • Be diagnosed with a psychiatric disorder.
  • Being diagnosed with an eating disorder.
  • Being under some nutritional food treatment.
  • Have a physical disability or injury that prevents you from engaging in mild to moderate physical activity.
  • Being under any pharmacological treatment for a medical condition.
  • Leaving the instruments unfinished.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral: Online Intervention Unisalud
Participants in this group will receive 9 sessions of a multi-component intervention focused on the reduction of the consumption of ultra processed foods, symptoms of anxiety, depression and stress and the increase of physical activity.
The "UNISALUD" intervention will be made up of 42 videos, made using the visual collage technique, where illustration, video fragments and visual interactions are mixed and in some there will be a presenter to achieve captivating visual material. to the participant. Likewise, it will be accompanied by digital infographics that will help reinforce the information proposed by the intervention.
No Intervention: No Intervention: Waiting List group
The participants in this group will not receive the treatment, just waiting list. They will be measured one time and then a second time 3 months after. Calculating when 3 months corresponding to 9 sessions will receive the intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the scores of the Frequency of Consumption
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
To evaluate and monitor the consumption of PUs, a Consumption Frequency with emphasis on processing will be used, which was adapted from the Nova screener for the consumption of ultra-processed foods and the Consumption Frequency of foods of adolescents and adults (12 years or older), used in the National Health and Nutrition Survey, 2019, which shows the foods commonly consumed in Mexico. This is a qualitative instrument that evaluates the consumption of PUs in three categories: a) drinks (12 items); b) products that replace or accompany meals (26 items); and c) unhealthy snacks (12 items). Intake is reported on a previous day (yes or no) and in frequency of consumption per month (never, once a month, once every 15 days, and 1 to 7 times a week or more than once a day). The cut-off points were delimited based on previous studies: a) High consumption: 5 or more products per day, b) Medium consumption: between 2 and 4 products per day and c) Low one or non products
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Change in time of the Physical Activity
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
The short version of International Physical Activity questionnarie consists of 7 items and provides information about the time the person spends doing moderate and vigorous intensity activities, walking, and sitting in the last seven days. The questionnaire classifies the level of activity carried out into three categories: low, moderate and high
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Change in the Scale in Self- Efficacy Eating Consumption Scale (SEECS)
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Self-Efficacy Eating consumption Scale, consisted of 21 items with a response option ranging from 1 to 10, where 1 represents the absence of capacity and 10 represents being very capable of reducing the intake of caloric products or sweets and change the consumption of healthy foods. In addition, they were asked if they engaged in any type of physical activity. This scale shows reliability criteria of (α = 0.93).
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Change in the Self-Efficacy for Exercise Questionnaire (SEEQ)
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
The Self- Efficacy for Exercise Questionnaire assesses the degree of confidence that people perceive to be physically active. The full scale is composed of 5 items that assess negative affect, resistance to relapse, and giving oneself time to be physically active. It is Likert-type and its response options range from 1 (not at all confident) to 5 (extremely confident).
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Change in the Sedentary behavior questionnarie (SBQ-s)
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
The SBQ-s has 11 items that assess the time spent on sedentary behaviors (e.g., watching television, eating while sitting, resting while lying down, driving or traveling by car, bus, or subway). These activities are evaluated on both a typical weekday and a weekend day. The response options are: "none," "15 minutes or less," "30 minutes," "1 hour," "2 hours," "3 hours," "4 hours," "5 hours," and "more than 6 hours." The time dedicated to each activity is converted into hours.
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Perceived Stress Scale
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Culturally the Perceive Stress Scale it has been adapted in Mexico by González-Ramírez & Landero-Hernández (2007). It is a Likert-type of 14 items with response options to 0 (never) to 4 (very often) to evaluate the degree to which situations in one's life are appraised as stressful.
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Change in the Generalized Anxiety Disorder Scale (GAD-7)
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
It is Likert-type of seven ítems and its response options range from 0 (not at all) - 3 (nearly every day). A score between 0 and 3 points indicates no perceived anxiety, and a score between 15 and 21 is an indicator of severe perceived anxiety
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
Change in the Center for Epidemiological Studies Depression Scale (CES-D)
Time Frame: 1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules
It was designed based on the study of clinical and general populations, and is currently one of the most widely used to assess depressive symptomatology in clinical and research settings at international and national level. It consists of 35 questions and contains five possible answers ranging from "Scarcely" (0 to 1 day), "Somewhat" (1-2 days), "Occasionally" (3-4 days), "Most" (5-7 days) and "Almost daily" (10-14 days).
1 to 1.5 months, depending on the development of the patient and the completion of the 9 modules

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Alejandro Dominguez Rodriguez, PhD, ITLAS group
  • Study Chair: Itzel Refugio Alvarado-Ávalos, BD, University of Guadalajara
  • Study Chair: Fátima López-Alcaraz, PhD, Universidad de Colima
  • Study Chair: Estefania Gasca-Suarez, BD, University of Guadalajara
  • Study Chair: Adrian Antonio Cisneros-Hernández, PhD, University of Guadalajara
  • Study Chair: Alexandra Valadez, PhD, University of Guadalajara
  • Study Chair: Fabiola Macías-Espinoza, PhD, University of Guadalajara

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

March 30, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

April 17, 2023

First Submitted That Met QC Criteria

April 17, 2023

First Posted (Actual)

April 28, 2023

Study Record Updates

Last Update Posted (Actual)

March 26, 2024

Last Update Submitted That Met QC Criteria

March 22, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UNISALUD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The information will be available in a private server or in a server of the journal(s) that we will publish the articles that will be the result of this study. The protocol of the study is currently in progress to be published, in this article will be included such study protocol, the informed consent is already shared in the register of clinical trials.

IPD Sharing Time Frame

This data will be available approximately in February 2024 and it will be permanently available. It will be shared in the databases of the journal where the article(s) will be published.

IPD Sharing Access Criteria

Through the servers of the journal(s) where we will publish the articles.

IPD Sharing Supporting Information Type

  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

3
Subscribe